Sign In
Buy SIBN
$15.84
+0.630 (+4.14%)
At Close: Jun 18, 2026
There are now 95 peer-reviewed publications demonstrating the safety, effectiveness, biomechanical or economic benefits of iFuse Technology™ There are now 95 peer-reviewed publications demonstrating
SANTA CLARA, Calif., July 02, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic an
French National Healthcare System Adopts Exclusive Reimbursement Policy for SI-BONE, Inc.'s iFuse-3D Implant System™
04:03pm, Tuesday, 15'th Jun 2021
Exclusive Coverage Takes Effect June 1, 2021, and Extends for 5 Years Exclusive Coverage Takes Effect June 1, 2021, and Extends for 5 Years
SI-BONE to Present at the 2021 JMP Securities Life Sciences Conference
04:03pm, Tuesday, 08'th Jun 2021
SANTA CLARA, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announce
SI-BONE, Inc. (SIBN) CEO Laura Francis on Q1 2021 Results - Earnings Call Transcript
08:26pm, Monday, 03'rd May 2021
SI-BONE, Inc. (SIBN) CEO Laura Francis on Q1 2021 Results - Earnings Call Transcript
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
07:34pm, Monday, 03'rd May 2021
Si-Bone (SIBN) delivered earnings and revenue surprises of 2.63% and 7.14%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Recap: SI-BONE Q1 Earnings
04:47pm, Monday, 03'rd May 2021
Shares of SI-BONE (NASDAQ:SIBN) remained quited after the company reported Q1 results. Quarterly Results Earnings per share were up 21.28% year over year to ($0.37), which beat the estimate of ($0.39)
SI-BONE, Inc. Reports First Quarter 2021 Financial Results and Reiterates 2021 Financial Guidance
04:03pm, Monday, 03'rd May 2021
SANTA CLARA, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported fi
SANTA CLARA, Calif., April 19, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic a
SI-BONE To Report First Quarter 2021 Financial Results on May 3, 2021
04:02pm, Thursday, 15'th Apr 2021
SANTA CLARA, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announce
SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q4 2020 Results - Earnings Call Transcript
11:20pm, Monday, 08'th Mar 2021
SI-BONE, Inc. (SIBN) CEO Jeff Dunn on Q4 2020 Results - Earnings Call Transcript
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates
07:44pm, Monday, 08'th Mar 2021
Si-Bone (SIBN) delivered earnings and revenue surprises of 6.67% and 0.43%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: SI-BONE Q4 Earnings
04:29pm, Monday, 08'th Mar 2021
Shares of SI-BONE (NASDAQ:SIBN) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 22.22% year over year to ($0.28), which beat the esti
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Issues 2021 Financial Guidance
04:03pm, Monday, 08'th Mar 2021
SANTA CLARA, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported
Earnings Outlook For SI-BONE
10:07am, Friday, 05'th Mar 2021
SI-BONE (NASDAQ:SIBN) releases its next round of earnings this Monday, March 08. Get the latest predictions in Benzinga's essential guide to the company's Q4 earnings report.
